Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
In the media 24 Apr 2026 Dengue treatments in 2-3 years, but cases set to rise with climate change Times of India
In the media 23 Apr 2026 India eyes dengue treatment rollout within five years as vaccine pipeline advances The New Indian Express
In the media 26 Mar 2026 Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030” El Mundo
Stories Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases
Scientific articles 14 Apr 2026 Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis Clinical and Translational Science
In the media 11 Apr 2026 Face à la dengue, la recherche s’active alors que le réchauffement laisse craindre une saison 2026 record Le Monde
Scientific articles 27 Mar 2026 Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review BMJ Public Health
Scientific articles 14 Jan 2026 (Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance The Lancet Microbe
Scientific articles 24 Mar 2026 The burden of eumycetoma in Africa: a neglected fungal disease The Lancet Regional Health – Africa
Statements 23 Mar 2026 DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement
News 13 Feb 2020 New laboratory adds much-needed capacity for mycetoma clinical research and treatment
News 30 Jan 2020 G-Finder Report: DNDi calls for increase in global R&D funding for NTDs on the first World NTD Day
News 27 Nov 2019 DNDi and partners hold seminar in Mexico aimed at improving access to diagnostics and treatment of Chagas disease
News 9 Oct 2019 DNDi welcomes GHIT support for a new collaboration with Mitsubishi Tanabe Pharma Corporation
News 15 Aug 2019 DNDi congratulates the TB Alliance for the FDA approval of a desperately-needed new treatment for drug-resistant forms of tuberculosis
News 26 Jun 2019 DNDi receives 1 billion yen from Takeda to improve access to treatment for neglected patients
